Ajinomoto Cambrooke
Pharmaceuticals, 4 Copeland Drive, Ayer, , 1432, Massachusetts, United States, 51-200 Employees
Phone Number: 15*********
Who is AJINOMOTO CAMBROOKE
Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a...
Read More
-
Headquarters: 4 Copeland Drive, Ayer, Massachusetts, 1432, United States
-
Date Founded: 2000
-
Employees: 51-200
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2833
|
NAICS Code: 325411 |
Show More
Does something look wrong? Fix it. | View contact records from AJINOMOTO CAMBROOKE
Ajinomoto Cambrooke Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Ajinomoto Cambrooke
Answer: Ajinomoto Cambrooke's headquarters are located at 4 Copeland Drive, Ayer, , 1432, Massachusetts, United States
Answer: Ajinomoto Cambrooke's phone number is 15*********
Answer: Ajinomoto Cambrooke's official website is https://cambrooke.com
Answer: Ajinomoto Cambrooke's SIC: 2833
Answer: Ajinomoto Cambrooke's NAICS: 325411
Answer: Ajinomoto Cambrooke has 51-200 employees
Answer: Ajinomoto Cambrooke is in Pharmaceuticals
Answer: Ajinomoto Cambrooke contact info: Phone number: 15********* Website: https://cambrooke.com
Answer: Ajinomoto Cambrooke, Inc. formerly Cambrooke Therapeutics, Inc. (expansion of Cambrooke Foods) was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely with nutritional intervention. The Paolellas goal in forming Cambrooke was simple - to develop improved nutritional therapeutic options for those with serious medical disorders. Today, Cambrooke produces medical formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases. Ajinomoto Cambrooke, Inc. - Leaders in Therapeutic Medical Nutrition. Cambrooke was the first medical foods company to launch a natural intact protein for the dietary management of phenylketonuria called GlytactinTM (modified glycomacropeptide). Cambrooke collaborates with academia and industry partners to transform early phase development projects in therapeutic nutrition into viable commercial products. Cambrooke employs scientific experts in the development, manufacturing and commercialization of nutritional therapeutics for patients with rare diseases. Cambrookes products are supported by clinical evidence for the nutritional management of medical needs before they are selected for commercialization. Cambrooke believes that both large and small patient populations are important when it comes to complex nutritional requirements.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month